» Articles » PMID: 18779341

Outer Surface Protein A Protects Lyme Disease Spirochetes from Acquired Host Immunity in the Tick Vector

Overview
Journal Infect Immun
Date 2008 Sep 10
PMID 18779341
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

The Lyme disease spirochete Borrelia burgdorferi alters the expression of outer surface protein (osp) genes as the bacterium cycles between ticks and mammals. OspA is produced as borreliae enter the tick vector and remains a major surface antigen during midgut colonization. To elucidate the role of OspA in the vector, we created an insertional deletion of ospA in strain B31-A3. The ospA mutant infects mice when it is injected intradermally and is acquired by larval ticks fed on these mice, where it persists through the molt to the nymph stage. Bacterial survival rates in artificially infected tick larvae fed on naïve mice were compared with those in the vector fed on immune mice. The ospA mutant proliferates in larvae if it is exposed to blood from naïve mice, but it declines in density after larval feeding if the blood is from immune mice. When uninfected larvae are fed on B-cell-deficient mice infected with the ospA mutant, larvae show borrelial densities and persistence that are significantly greater than those fed on infected, immunocompetent mice. We conclude that OspA serves a critical antibody-shielding role during vector blood meal uptake from immune hosts and is not required for persistence in the tick vector.

Citing Articles

Characterization and genomic analysis of the Lyme disease spirochete bacteriophage ϕBB-1.

Faith D, Kinnersley M, Brooks D, Drecktrah D, Hall L, Luo E PLoS Pathog. 2024; 20(4):e1012122.

PMID: 38558079 PMC: 11008901. DOI: 10.1371/journal.ppat.1012122.


Characterization and genomic analysis of the Lyme disease spirochete bacteriophage ϕBB-1.

Faith D, Kinnersley M, Brooks D, Drecktrah D, Hall L, Luo E bioRxiv. 2024; .

PMID: 38260690 PMC: 10802411. DOI: 10.1101/2024.01.08.574763.


Longitudinal map of transcriptome changes in the Lyme pathogen during tick-borne transmission.

Sapiro A, Hayes B, Volk R, Zhang J, Brooks D, Martyn C Elife. 2023; 12.

PMID: 37449477 PMC: 10393048. DOI: 10.7554/eLife.86636.


Probing the Role of a Highly Conserved Gene of the Lyme Disease Spirochete, Throughout the Mouse-Tick Infectious Cycle.

Bhatia B, Hillman C, Stewart P, Rosa P Infect Immun. 2021; 89(12):e0033321.

PMID: 34581605 PMC: 8594592. DOI: 10.1128/IAI.00333-21.


Lyme Disease Pathogenesis.

Coburn J, Garcia B, Hu L, Jewett M, Kraiczy P, Norris S Curr Issues Mol Biol. 2020; 42:473-518.

PMID: 33353871 PMC: 8046170. DOI: 10.21775/cimb.042.473.


References
1.
Thanassi W, Schoen R . The Lyme disease vaccine: conception, development, and implementation. Ann Intern Med. 2000; 132(8):661-8. DOI: 10.7326/0003-4819-132-8-200004180-00009. View

2.
Donahue J, Piesman J, Spielman A . Reservoir competence of white-footed mice for Lyme disease spirochetes. Am J Trop Med Hyg. 1987; 36(1):92-6. DOI: 10.4269/ajtmh.1987.36.92. View

3.
Steere A, Sikand V, Meurice F, Parenti D, Fikrig E, Schoen R . Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med. 1998; 339(4):209-15. DOI: 10.1056/NEJM199807233390401. View

4.
Grimm D, Tilly K, Byram R, Stewart P, Krum J, Bueschel D . Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc Natl Acad Sci U S A. 2004; 101(9):3142-7. PMC: 365757. DOI: 10.1073/pnas.0306845101. View

5.
Piesman J, Zeidner N, Schneider B . Dynamic changes in Borrelia burgdorferi populations in Ixodes scapularis (Acari: Ixodidae) during transmission: studies at the mRNA level. Vector Borne Zoonotic Dis. 2003; 3(3):125-32. DOI: 10.1089/153036603768395825. View